Multiwave attracts CHF 3.8m in fresh capital from Ava Investors and existing investors

Geneva-based investment firm Ava Investors led two consecutive capital increases in Multiwave to support Multiwave’s path to FDA approval for its portable MRl. The investment totaling CHF 2.3m in July and August 2023 comes on top of a CHF 1.47m convertible invested by existing investors and Fongit Innovation Fund earlier that year which converted with Ava Investor-led capital increase.